ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 132 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $133,044 | -47.9% | 6,217 | -1.6% | 0.00% | -33.3% |
| Q1 2023 | $255,459 | -15.2% | 6,317 | -2.4% | 0.00% | -25.0% |
| Q4 2022 | $301,077 | -10.1% | 6,472 | +0.2% | 0.00% | -20.0% |
| Q3 2022 | $335,000 | +17.1% | 6,458 | +6.7% | 0.01% | +25.0% |
| Q2 2022 | $286,000 | -40.3% | 6,051 | -10.0% | 0.00% | -20.0% |
| Q1 2022 | $479,000 | -7.5% | 6,727 | -2.9% | 0.01% | -16.7% |
| Q4 2021 | $518,000 | +27.0% | 6,927 | -3.6% | 0.01% | +20.0% |
| Q3 2021 | $408,000 | +29.1% | 7,182 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $316,000 | -10.7% | 7,182 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $354,000 | +18.8% | 7,182 | +1.4% | 0.00% | 0.0% |
| Q4 2020 | $298,000 | +0.3% | 7,082 | +9.1% | 0.00% | 0.0% |
| Q3 2020 | $297,000 | -8.9% | 6,494 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $326,000 | -2.4% | 6,494 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $334,000 | -16.7% | 6,494 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $401,000 | +2.8% | 6,494 | 0.0% | 0.01% | +20.0% |
| Q3 2019 | $390,000 | -25.4% | 6,494 | +4.8% | 0.01% | -28.6% |
| Q2 2019 | $523,000 | -10.1% | 6,194 | +1.6% | 0.01% | -12.5% |
| Q1 2019 | $582,000 | +37.3% | 6,094 | +1.8% | 0.01% | +14.3% |
| Q4 2018 | $424,000 | – | 5,984 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |